Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;39(12):11125-30.
doi: 10.1007/s11033-012-2020-2. Epub 2012 Oct 12.

Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer

Affiliations

Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer

Nega Berhane et al. Mol Biol Rep. 2012 Dec.

Abstract

Prostate cancer (PCa) is the most common noncutaneous cancer among men, accounting for 10 % of male cancer-related deaths worldwide. The etiology of PCa is largely unknown, although multiple environmental and lifestyle factors such as ultraviolet irradiation, smoking, and diet might increase the risk of the disease. Risk of disease varies most prominently with age, ethnicity, family history, and diet. The multifunctional cytokine tumor necrosis factor alpha (TNF-α) has an important role in the pathogenesis of inflammatory, autoimmune and malignant diseases. In this case control study 150 Prostate cancer patients and 150 age matched benign prostate hyperplasia (BPH) and equal number of healthy control groups were involved. The aim of this study was to analyze the effect of TNF-α-308 (G/A) polymorphism on risk of prostate cancer on north Indian prostate cancer patients. The polymerase chain reaction (PCR) technique was utilized to genotype TNF-α-308 (G/A) polymorphism. The present study showed statistically significant increased risk of prostate cancer among individuals that carried the A allele of TNF-α-308 gene (OR = 1.81, 95 % CI 1.00-3.481, p = 0.03).

PubMed Disclaimer

References

    1. Exp Mol Pathol. 2007 Aug;83(1):54-8 - PubMed
    1. PLoS One. 2011;6(7):e22092 - PubMed
    1. Microsc Res Tech. 2000 Aug 1;50(3):216-28 - PubMed
    1. J Chin Med Assoc. 2006 Aug;69(8):351-7 - PubMed
    1. Rev Urol. 2001;3 Suppl 2:S2-S10 - PubMed

Substances

LinkOut - more resources